Long-term treatment with interleukin-1β induces insulin resistance in murine and human adipocytes

Diabetologia

Volumn 49, Issue 9, 2006, Pages 2162-2173

  Lagathu, C ^a   Yvan Charvet, L ^a   Bastard, J P ^a,b   Maachi, M ^a,b   Quignard Boulange A ^a   Capeau, J ^a,b   Caron, M ^a  

^a INSERM   (France)

^b HÔPITAL TENON   (France)

Author keywords

Adiponectin; Adipose tissue; Cytokine; Differentiation; Inflammation; Insulin signalling; Mouse

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ADIPONECTIN; CCAAT ENHANCER BINDING PROTEIN ALPHA; FATTY ACID SYNTHASE; INSULIN RECEPTOR; INSULIN RECEPTOR BETA; INSULIN RECEPTOR SUBSTRATE 1; INTERLEUKIN 1BETA; LIPID; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOSE TISSUE; ADIPOSE TISSUE CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DOWN REGULATION; EPIDIDYMIS FAT; GENE EXPRESSION; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID METABOLISM; LIPOGENESIS; LIPOLYSIS; LONG TERM CARE; MALE; MOUSE; NONHUMAN; OBESITY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; UPREGULATION;

3T3 CELLS; ADIPOCYTES; ADIPONECTIN; ADIPOSE TISSUE; ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOSE; HUMANS; INFLAMMATION; INSULIN; INSULIN RESISTANCE; INTERLEUKIN-1BETA; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS;

EID: 33746736936     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-006-0335-z     Document Type: Article

References (42)

1. Haffner SM, D'Agostino Jr R, Mykkanen L et al (1999) Insulin sensitivity in subjects with type 2 diabetes. Relationship to cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study. Diabetes Care 22:562-568
2. Hotamisligil GS (2003) Inflammatory pathways and insulin action. Int J Obes 27(Suppl 3):S53-S55
3. Weisberg SP, McCann D, Desai M et al (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112:1796-1808
4. Xu H, Barnes GT, Yang Q et al (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112:1821-1830
5. Bastard JP, Maachi M, Tran Van Nhieu J et al. (2002) Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. J Clin Endocrinol Metab 87:2084-2089
6. Bruun JM, Verdich C, Toubro S, Astrup A, Richelsen B (2003) Association between measures of insulin sensitivity and circulating levels of interleukin-8, interleukin-6 and tumor necrosis factor-alpha. Effect of weight loss in obese men. Eur J Endocrinol 148:535-542
7. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM (1995) Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 95:2409-2415
8. Bunout D, Munoz C, Lopez M et al (1996) Interleukin 1 and tumor necrosis factor in obese alcoholics compared with normal-weight patients. Am J Clin Nutr 63:373-376
9. Um JY, Chung HS, Song MY, Shin HD, Kim HM (2004) Association of interleukin-1 beta gene polymorphism with body mass index in women. Clin Chem 50:647-650
10. Spranger J, Kroke A, Mohlig M et al (2003) Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 52:812-817
11. Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW (2004) Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 145:2273-2282
12. Juge-Aubry CE, Somm E, Chicheportiche R et al (2004) Regulatory effects of interleukin (IL)-1, interferon-beta, and IL-4 on the production of IL-1 receptor antagonist by human adipose tissue. J Clin Endocrinol Metab 89:2652-2658
13. Lihn AS, Bruun JM, He G et al (2004) Lower expression of adiponectin mRNA in visceral adipose tissue in lean and obese subjects. Mol Cell Endocrinol 219:9-15
14. Berg AH, Combs TP, Scherer PE (2002) ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 13:84-89
15. Weyer C, Funahashi T, Tanaka S et al (2001) Hypoadiponectine-mia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86:1930-1935
16. Fain JN, Bahouth SW, Madan AK (2005) Involvement of multiple signaling pathways in the post-bariatric induction of IL-6 and IL-8 mRNA and release in human visceral adipose tissue. Biochem Pharmacol 69:1315-1324
17. Flower L, Gray R, Pinkney J, Mohamed-Ali V (2003) Stimulation of IL-6 release by IL-1beta from isolated human adipocytes. Cytokine 21:32-37
18. Bruun JM, Lihn AS, Pedersen SB, Richelsen B (2005) Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT. J Clin Endocrinol Metab 90:2282-2289
19. Fain JN, Madan AK (2005) Regulation of monocyte chemoattractant protein 1 (MCP-1) release by explants of human visceral adipose tissue. Int J Obes 29:1299-1307
20. Christiansen T, Richelsen B, Bruun JM (2005) Monocyte chemoattractant protein-1 is produced in isolated adipocytes, associated with adiposity and reduced after weight loss in morbid obese subjects. Int J Obes 29:146-150
21. Juge-Aubry CE, Somm E, Giusti V et al (2003) Adipose tissue is a major source of interleukin-1 receptor antagonist: upregulation in obesity and inflammation. Diabetes 52:1104-1110
22. Somm E, Cettour-Rose P, Asensio C et al (2006) Interleukin-1 receptor antagonist is upregulated during diet-induced obesity and regulates insulin sensitivity in rodents. Diabetologia 49:387-393
23. Fantuzzi G (2005) Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115:911-919; quiz 920
24. Wewers MD (2004) IL-1beta: an endosomal exit. Proc Natl Acad Sci USA 101:10241-10242
25. Lagathu C, Bastard JP, Auclair M et al (2003) Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: prevention by rosiglitazone. Biochem Biophys Res Commun 311:372-379
26. Lagathu C, Bastard JP, Auclair M et al (2004) Antiretroviral drugs with adverse effects on adipocyte lipid metabolism and survival alter the expression and secretion of proinflammatory cytokines and adiponectin in vitro. Antivir Ther 9:911-920
27. Zhang HH, Kumar S, Barnett AH, Eggo MC (2001) Dexamethasone inhibits tumor necrosis factor-alpha-induced apoptosis and interleukin-1 beta release in human subcutaneous adipocytes and preadipocytes. J Clin Endocrinol Metab 86:2817-2825
28. Hotamisligil GS, Peraldi P, Budavari A et al (1996) IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 271:665-668
29. Rotter V, Nagaev I, Smith U (2003) Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects. J Biol Chem 278:45777-45784
30. Sethi J, Hotamisligil G (1999) The role of TNF alpha in adipocyte metabolism. Semin Cell Dev Biol 10:19-29
31. Briquet-Laugier V, Dugail I, Ardouin B et al (1994) Evidence for a sustained genetic effect on fat storage capacity in cultured adipose cells from Zucker rats. Am J Physiol 267:E439-E446
32. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ (1979) Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294-5299
33. Wu Z, Rosen ED, Brun R et al (1999) Cross-regulation of C/EBP alpha and PPAR gamma controls the transcriptional pathway of adipogenesis and insulin sensitivity. Mol Cell 3:151-158
34. Mauvais-Jarvis F, Kulkarni RN, Kahn CR (2002) Knockout models are useful tools to dissect the pathophysiology and genetics of insulin resistance. Clin Endocrinol (Oxf) 57:1-9
35. Radziuk J (2000) Insulin sensitivity and its measurement: structural commonalities among the methods. J Clin Endocrinol Metab 85:4426-4433
36. Dandona P, Aljada A, Bandyopadhyay A (2004) Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol 25:4-7
37. Feingold KR, Doerrler W, Dinarello CA, Fiers W, Grunfeld C (1992) Stimulation of lipolysis in cultured fat cells by tumor necrosis factor, interleukin-1, and the interferons is blocked by inhibition of prostaglandin synthesis. Endocrinology 130:10-16
38. Emanuelli B, Glondu M, Filloux C, Peraldi P, Van Obberghen E (2004) The potential role of SOCS-3 in the interleukin-1beta-induced desensitization of insulin signaling in pancreatic beta-cells. Diabetes 53 (Suppl 3):S97-S103
39. He J, Usui I, Ishizuka K et al (2005) Interleukin-1alpha inhibits insulin signaling with phosphorylating IRS-1 on serine residues in 3T3-L1 adipocytes. Mol Endocrinol 20:114-124
40. Cowherd RM, Lyle RE, McGehee RE Jr (1999) Molecular regulation of adipocyte differentiation. Semin Cell Dev Biol 10:3-10
41. Bruun JM, Lihn AS, Verdich C et al (2003) Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. Am J Physiol Endocrinol Metab 285:E527-E533
42. Maeda N, Takahashi M, Funahashi T et al (2001) PPAR-gamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 50:2094-2099